SUMMARY We describe a long term study of 76 patients with dermatitis herpetiformis. Unlike patients with coeliac disease, where the peak incidence was during the first and fourth decades, no dermatitis herpetiformis patients presented in the first decade; also, there was a male preponderance in dermatitis herpetiformis which contrasts with the excess of females in coeliac disease. The apparent prevalence of dermatitis herpetiformis was 11 per 100 000 in our population; approximately one fifth of that of coeliac disease. Jejunal villous atrophy was present in 78% of our dermatitis herpetiformis patients, and a single jejunal biopsy was as effective at detecting this as the multiple biopsy technique. A majority of patients were able to stop, or radically reduce their dapsone or sulphapyridine treatment after the institution of a gluten free diet. Spontaneous remission of the skin lesion occurred in only two patients not receiving a gluten free diet. Gastric parietal or thyroid antibodies were detected in 38% of patients, and three cases of thyroid disease and two cases of pernicious anaemia were detected. Lymphoma developed in two patients, one being intestinal in origin. We conclude that a gluten free diet is of therapeutic benefit in dermatitis herpetiformis and that spontaneous remission is uncommon in those not on a diet. Despite patchiness of the enteropathy, a single jejunal biopsy is quite adequate to diagnose the presence of upper intestinal villous atrophy.
Since the first report of the association of dermatitis herpetiformis with coeliac disease in 1966,1 evidence of close links between the two disorders has accumulated. Well documented points of similarity include the response of the enteropathy to a gluten free diet,23 the high prevalence of HLA B8 and DR3 phenotypes, the occurrence of hyposplenism78 and a predisposition to the development of lymphoma.9 10 While these associations are not in dispute, controversy has arisen in relation to the major differences between the two disorders. By definition, the appearance of the skin lesions characterises dermatitis herpetiformis, but, while some authors believe that exclusion of gluten from the diet leads to remission of the skin disease 11-14 others disagree.5 16 Similarly, there is disagreement about the frequency with which intestinal villous atrophy occurs in dermatitis herpetiformis. Some investigators have observed a normal jejunal mucosa in about one third of all patients with dermatitis herpetiformis, 17 18 but Brow and coworkers19 have claimed that enteropathy is almost always demonstrable, provided a sufficient number of biopsies is taken. Evidence of patchiness of the intestinal lesion19 20 has helped to create the suspicion that a single jejunal biopsy may not be an adequate basis for assessment of the small intestine in dermatitis herpetiformis, and that sampling variation may sometimes produce a normal biopsy from an abnormal intestine.
This report outlines our experience with dermatitis herpetiformis, which we believe is now large enough for us to comment on several current controversies, including the effect of a gluten free diet on the skin rash, the need for multiple small bowel biopsies, and the relationship of dermatitis herpetiformis with coeliac disease, and with recognised autoimmune disorders.
Methods

PATIENTS
Seventy six patients with dermatitis herpetiformis, referred by consultants within the south east region of Scotland, have been investigated and followed up at a clinic run jointly by a dermatologist and a gastroenterologist over the last 11 years. These criteria were fulfilled in two patients, one having negative immunofluorescence on two skin biopsies and one whose skin had never been studied by immunofluorescence.
Small bowel biopsy was carried out in all patients except eight in whom it was contraindicated or refused. Single biopsies were performed using a Crosby or Watson capsule, sampling from the jejunum at the level of the ligament of Treitz. Multiple biopsies were obtained with a Quinton hydraulic suction biopsy instrument, taking six biopsies from the proximal jejunum back to the fourth part of the duodenum. A gluten free diet in which wheat, barley, and oat products were excluded, was started in all 53 patients who had villous atrophy, in five with normal small bowel biopsies who responded poorly to drug treatment and in three who had not had intestinal biopsies performed. Before the diet, the minimum dose of sulphapyridine or dapsone required to control the skin symptoms was established and after the diet had begun the patients were encouraged to reduce the dosage of drugs whenever possible and ultimately to stop them. Patients were reviewed three months after starting the diet and then usually at six monthly intervals.
Information on coeliac disease patients was obtained from the coeliac register compiled by the Gastrointestinal Unit of the Western General Hospital, Edinburgh. Data for sex and age at presentation of 324 coeliac patients in the Lothian Region born before 1963 were analysed together with figures for the prevalence of coeliac disease in Lothian Region.21 Information on sex and age at presentation was obtained for 76 dermatitis herpetiformis patients from south-east Scotland and the prevalence of dermatitis herpetiformis in Lothian Region was calculated for comparison with the data for coeliac disease.
Where statistical significance is quoted, the method of analysis is the x2 test.
Results
SEX AND AGE
The dermatitis herpetiformis patients comprised 49 men (64%) and 27 women (36%); a male to female ratio of 1-81: 1. The mean age at presentation was 43 years for men (range 16-75 years) and 38 years for women (range 12-77 years). The greatest number of patients presented in the fourth decade and there were no cases in the first 10 years of life (Fig. 1 ). This contrasts with coeliac disease which has its highest incidence during the first decade. If these early cases are excluded, however, the age distribution of coeliac disease is similar to dermatitis herpetiformis (Fig. 2) . The coeliac disease patients showed a male to female ratio of 1:1 89 which is statistically different from that of dermatitis herpetiformis (p<0-01). 
EFFECT OF GLUTEN FREE DIET ON DRUG THERAPY
Sixty one patients started a gluten free diet but 10 did not adhere to it and were asked to stop. Nine others admitted to occasional dietary indiscretion but the remaining 42 reported that they were strictly adhering to the diet. Of the 51 who continued on a gluten free diet, 27 patients (53%) were able to stop dapsone or sulphapyridine completely and in 12 others (23.5%) the drug requirements were reduced by at least 50%. Twelve patients were not able to reduce their drug dosage but four of these have only been on the diet for less than 12 months.
Drug requirements fell to 50% of the pre-gluten free diet level in an average of 18 months after starting the diet for the 39 patients who managed to reduce their drug intake or subsequently discontinue it altogether (Fig. 3) . The time to achieve this reduction ranged from one to 103 months with 17 patients taking less than six months. Twenty seven patients were able to discontinue their dapsone or sulphapyridine; the mean time required was 25 months after the gluten free diet began (range 1-91 months) and five patients stopped their medication in less than six months (Fig. 4) . These Any thyroid 20 30 Thyroid cytoplasm 4 6 Thyroid microsome 15 23 Thyroglobulin 8 12 All 3 thyroid 2 3 Gastric parietal cell 9 14 our patients, both with jejunal villous atrophy, have developed a lymphoma. The first died from a small bowel lymphoma despite chemotherapy, and the second, with a non-intestinal lymphoma is undergoing chemotherapy. Both had been on a gluten free diet although each admitted to some dietary indiscretion. A gluten free diet has not been shown to decrease the incidence of intestinal lymphoma in coeliac disease,9 22 and thus in dermatitis herpetiformis patients with villous atrophy, who rarely have malabsorption, the theoretical benefit of prescribing a gluten free diet purely for the enteropathy is questionable. Despite this lack of evidence, however, the current consensus favours such treatment, mainly because most patients are able to stop or reduce their drug intake by taking a gluten free diet.
Between a third and a fifth of dermatitis herpetiformis patients do not have small bowel villous atrophy, 17 18 and it is puzzling that the skin lesions in a number of these respond to a gluten free diet.12 Brow et al19 believed the intestinal lesion to be patchy and concluded that mucosal abnormalities were almost invariably to be found if enough biopsies were taken. Only one of their 22 patients had a normal jejunal biopsy although six showed a histological variation from almost normal to completely flat. Scott and Losowsky20 found patchiness of villous atrophy in dermatitis herpetiformis and coeliac disease patients studied by multiple biopsy, and concluded that this investigation was 'invaluable'. Our findings confirm reports that the degree of villous atrophy is variable in some patients. Although two out of 27 of our dermatitis herpetiformis patients studied by multiple biopsy showed normal villi in one third of specimens, it is unlikely that a single biopsy would have been completely normal because it provides a larger sample of mucosa than that obtained each time with the multiple technique. Multiple biopsy is without doubt a useful research investigation but we have found no evidence that a single biopsy taken with a Watson or Crosby capsule is manifestly inferior to the multiple technique for diagnostic purposes.
Dermatitis herpetiformis and coeliac disease both have a higher prevalence of HLA B8 and DR3 phenotypes than the normal population.46 These HLA antigens are often associated with autoimmune disease, although neither dermatitis herpetiformis nor coeliac disease belongs in this category. This may, however, explain the increased prevalence of thyroid and parietal cell antibodies in our patients and in previous series. 18 23 Achlorhydria or hypochlorhydria is present in over 50% of dermatitis herpetiformis cases,24 and suggests that pernicious anaemia might be common in dermatitis herpetiformis. Despite the raised prevalence of autoantibodies in our group, autoimmune thyroid disease and pernicious anaemia were encountered relatively infrequently.
Granular IgA deposits in the dermal papillae of non-involved skin are said by some to be mandatory for diagnosing dermatitis herpetiformis.25 Patients have been described with negative immunofluorescence, however, but with all the clinical hallmarks of this disease. 13 26 We are not convinced that the demonstration of granular IgA is an absolute prerequisite provided all other criteria are satisfied, and we have included any patients able to meet these.
Coeliac disease results from an abnormal response of the small bowel to gluten and is associated with altered immunological function.27 A similar situation may exist in dermatitis herpetiformis, although the pathogenetic mechanisms here must in addition explain the skin lesions. We find that dermatitis herpetiformis is nearly twice as common in men as in women; this confirms previous observations,28 29 and is almost the reverse of the finding in coeliac disease. The frequent presentation of coeliac disease in the first decade contrasts with the rarity of such an early occurrence in dermatitis herpetiformis, although thereafter the age incidences are similar. We are unable to show any correlation between the prevalence of coeliac disease and dermatitis herpetiformis by year of birth, a finding which, if positive, might have suggested an environmental factor influencing both disorders. Between 1975 and 1979, there was a two fold increase in the number of coeliacs diagnosed in the Lothian Region compared with the preceding five years.30 No corresponding increase in the number of dermatitis herpetiformis patients has been noted.
The exact relationship between the skin and gut lesions of dermatitis herpetiformis remains obscure, although the fact that both respond to a gluten free diet suggests that they are linked and that gluten may be involved in the pathogenesis of the rash. The IgA in the skin has characteristics of dimeric IgA and hence probably originates in the gut.3' IgA containing circulating immune complexes were found to be significantly raised after the oral ingestion of wheat in five out of five dermatitis herpetiformis patients, two with previously normal IgA circulating immune complex levels.32 This suggests that IgA circulating immune complexes are stimulated by ingested wheat antigens (presumably gluten) and then lodge in the dermal papillae for as yet unknown reasons. Circumstantial evidence for a circulating factor comes from our observation of one patient whose dapsone requirement fell for six months after a major gastrointestinal haemorrhage which complicated jejunal biopsy and necessitated a transfusion of 15 units of blood. The rash of dermatitis herpetiformis, however, is unlikely to be due simply to wheat antigen induced circulating immune complexes because an average of two years on a gluten free diet is required for the eruption to clear and dermal IgA persists long after the rash has cleared on gluten exclusion. 33 Our findings confirm the beneficial effect of a gluten free diet and a single jejunal biopsy can now be used with confidence to detect intestinal villous atrophy in dermatitis herpetiformis. We have highlighted areas of disparity as well as points of similarity between dermatitis herpetiformis and coeliac disease, but the relationships between these disorders, and between gluten and the rash, remain unexplained despite recent immunological advances. Future research may resolve these difficulties by concentrating on the differences between dermatitis herpetiformis and coeliac disease, rather than pursuing points of similarity.
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